The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
November 4, 2020
State Health Policy Leadership COVID-19
Back to News and Updates
By Roxanne Bangalan
Delaware, New Jersey, and Rhode Island announced last week a commitment to a common framework for COVID-19 testing for high-risk, asymptomatic residents and for financing this testing.
The absence of federal guidance on national testing protocols has put states at the helm of decisions about who and how to test their residents. With potential demand for testing exceeding supply, a shared and consistent evidence-informed approach to policymaking maximizes limited resources and improves the quality of the findings.
With support from the Milbank Memorial Fund and Center for Evidence-based Policy, the states identified priority populations for asymptomatic testing, including residents and staff in skilled nursing, assisted living, and other group settings, immunocompromised individuals, workers with high exposure risk, people experiencing homelessness, and asymptomatic people with known exposure. The states also outlined key strategies for testing in those populations and developed an approach to financing.
In a joint statement, governors emphasized using testing to mitigate the spread of the virus and ensure the “safe, sustainable re-opening of economies.” The governors underscored the following six principles in their science-based approach:
States devised a coordinated testing strategy involving baseline and intermittent follow-up testing adapted to local prevalence rates and encouraging standardized reporting of all test results. Other preventative safety measures such as hand hygiene, appropriate use of personal protective equipment (PPE), disinfecting, and physical distancing will continue.
To ensure coverage for asymptomatic testing and treatment, the states will consider issuing medical standards and guidance that specify the categories of individuals at high risk for COVID-19 and asymptomatic transmission, ensure evaluation of these individuals is not required prior to testing, and determine how test results will be reported to patients. In addition, the state agencies with oversight for private insurance will consider clarifying that the state’s standard for payment or medical necessity has been met and directing private insurance carriers to cover SARS-CoV-2 testing and treatment for these high-risk populations.
“We know that a strategic asymptomatic testing plan is one of our strongest lines of defense against the spread of COVID-19,” said Rhode Island Governor Gina M. Raimondo. “As case numbers spike across the country, it’s more important now than ever that we’re taking the most effective interventions possible. I’m grateful to my fellow governors for their collaboration as we follow this shared approach to keep our residents safe.”
Jul 6, 2020
Apr 2, 2020
Get the Latest from the Milbank Memorial Fund
An endowed operating foundation that engages in nonpartisan analysis, collaboration, and communication, with an emphasis on state health policy.